omeprazole has been researched along with Alcohol Drinking in 12 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a preliminary study to compare the effects of different doses of omeprazole 44 patients with endoscopically diagnosed duodenal ulceration randomly received omeprazole 20 mg, 30 mg, 40 mg, or 60 mg daily for four weeks." | 9.05 | Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing, and recurrence. Cooperative study. ( , 1984) |
| "In a preliminary study to compare the effects of different doses of omeprazole 44 patients with endoscopically diagnosed duodenal ulceration randomly received omeprazole 20 mg, 30 mg, 40 mg, or 60 mg daily for four weeks." | 5.05 | Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing, and recurrence. Cooperative study. ( , 1984) |
| "To evaluate endogenous and exogenous factors affecting the quality of ulcer healing produced by proton pump inhibitors, gastric acid pH, serum gastrin, and serum pepsinogen (PG) I and II were measured in peptic ulcer patients before and after treatment with lansoprazole 30 mg once daily." | 3.69 | Factors affecting quality of ulcer healing after lansoprazole treatment. ( Hanai, H; Ito, G; Kaneko, E; Nakagawara, M; Nawano, M; Ooi, S; Watanabe, F, 1995) |
| "Lansoprazole is a new proton pump inhibitor which produces prolonged decrease of gastric acidity." | 2.68 | A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group. ( Avner, D; Greski-Rose, PA; Jennings, DE; Jhala, N; Robinson, M; Sahba, B, 1995) |
| "Posttreatment clarithromycin resistance is common in patients who do not experience success with therapy." | 2.68 | Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. ( Axon, AT; Chalmers, DM; Dixon, MF; Langworthy, H; Moayyedi, P; Shanahan, K; Tompkins, DS, 1996) |
| " The effects of a minimum of 2 weeks of dosing with cimetidine, ranitidine and omeprazole were examined." | 1.30 | Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions. ( Brown, AS; James, OF, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, T | 1 |
| Oota, K | 1 |
| Harada, S | 1 |
| Edogawa, S | 1 |
| Kojima, Y | 1 |
| Sanomura, M | 1 |
| Sakaguchi, M | 1 |
| Hayashi, K | 1 |
| Hongoh, Y | 1 |
| Itabashi, T | 1 |
| Kitae, H | 1 |
| Hoshimoto, M | 1 |
| Takeuchi, N | 1 |
| Higuchi, K | 1 |
| Grad, YH | 1 |
| Seifter, JL | 1 |
| Levy, BD | 1 |
| Loscalzo, J | 1 |
| O'Leary, C | 1 |
| McCarthy, J | 1 |
| Humphries, M | 1 |
| Shanahan, F | 1 |
| Quigley, E | 1 |
| Ito, G | 1 |
| Nakagawara, M | 1 |
| Watanabe, F | 1 |
| Ooi, S | 1 |
| Nawano, M | 1 |
| Hanai, H | 1 |
| Kaneko, E | 1 |
| Robinson, M | 1 |
| Sahba, B | 1 |
| Avner, D | 1 |
| Jhala, N | 1 |
| Greski-Rose, PA | 1 |
| Jennings, DE | 1 |
| Moayyedi, P | 2 |
| Chalmers, DM | 2 |
| Axon, AT | 2 |
| Langworthy, H | 1 |
| Shanahan, K | 1 |
| Tompkins, DS | 1 |
| Dixon, MF | 1 |
| Brown, AS | 1 |
| James, OF | 1 |
| Soga, T | 1 |
| Matsuura, M | 1 |
| Kodama, Y | 1 |
| Fujita, T | 1 |
| Sekimoto, I | 1 |
| Nishimura, K | 1 |
| Yoshida, S | 1 |
| Kutsumi, H | 1 |
| Fujimoto, S | 1 |
| Namiot, Z | 1 |
| Namiot, DB | 1 |
| Kemona, A | 1 |
| Gołebiewska, M | 1 |
| Bucki, R | 1 |
| Baena, JM | 1 |
| López, C | 1 |
| Hidalgo, A | 1 |
| Rams, F | 1 |
| Jiménez, S | 1 |
| García, M | 1 |
| Hernández, MR | 1 |
8 trials available for omeprazole and Alcohol Drinking
| Article | Year |
|---|---|
Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Anxiety; Cytochrome P-450 CYP2C19; Depression; Dos | 2015 |
The prophylactic use of a proton pump inhibitor before food and alcohol.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alcohol Drinking; Anti-Ulcer Agents; Double-Blind Me | 2003 |
Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing, and recurrence. Cooperative study.
Topics: Adult; Aged; Alcohol Drinking; Anti-Ulcer Agents; Benzimidazoles; Depression, Chemical; Duodenal Ulc | 1984 |
A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Alcohol Drinking; Anti-Ulcer Agents; | 1995 |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Clarithromycin; Drug Therapy | 1996 |
Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
Topics: Alcohol Drinking; Case-Control Studies; Endoscopy, Digestive System; Enzyme Inhibitors; Esophagitis, | 1999 |
[The effect of cigarette smoking and alcohol consumption on efficacy of Helicobacter pylori eradication].
Topics: Adult; Alcohol Drinking; Amoxicillin; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female | 2000 |
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.
Topics: Adult; Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 2002 |
4 other studies available for omeprazole and Alcohol Drinking
| Article | Year |
|---|---|
Clinical problem-solving. Bitter pills.
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Diagnosis, Di | 2010 |
Factors affecting quality of ulcer healing after lansoprazole treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Alcohol Drinking; Anti-Ulcer Agents; Duodenal | 1995 |
Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1997 |
Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions.
Topics: Adult; Alcohol Drinking; Area Under Curve; Central Nervous System Depressants; Cimetidine; Ethanol; | 1998 |